The cost of multiple sclerosis (MS) in Australia has surpassed $3 billion a year for the first time, driven by a substantial rise in prevalence, according to a major new report.
The report, Multiple Sclerosis Prevalence and Health Economic Impact in Australia 2025, commissioned by MS Australia and produced in collaboration with the Menzies Institute for Medical Research, University of Tasmania, reveals that a record 37,756 Australians are now living with the chronic neurological disease – a 13.3% increase in just three years since 2021.
